Meningococcal group B disease (MenB) is a severe bacterial infection that can lead to meningitis and septicaemia, causing serious illness, long-term disabilities, or even death. In the United Kingdom, a national vaccination program targets infants, offering protection against this specific strain due to their increased vulnerability.
However, the current vaccination schedule does not extend to older teenagers and young adults. This demographic, including university students, has recently become a focal point of discussion following a cluster of cases in areas like Kent, where individuals in this age group have contracted the disease and were not immunised under the existing scheme. The absence of a universal MenB vaccine for teenagers in the UK is rooted in a policy decision informed by various factors, primarily the recommendations of the Joint Committee on Vaccination and Immunisation (JCVI).
The JCVI evaluates the clinical effectiveness and cost-effectiveness of vaccines for the national program. While the vaccine is highly effective, the disease burden is historically highest in infants, leading to the prioritisation of this age group for routine vaccination. Extending the program to older teenagers would involve significant financial investment and logistical challenges. Arguments against expanding the program for adolescents also highlight the overall lower incidence rate compared to babies, and the need to balance public health benefit against resource allocation.
Conversely, strong arguments support offering the MenB vaccine to teenagers. Entering university or similar environments often involves increased close contact, which can elevate the risk of transmission. The consequences of MenB infection for older teens can be just as devastating as for infants, leading to long-term health problems or fatalities. Proponents argue that universal vaccination for this group would close a significant gap in protection, reducing suffering and the societal cost of managing severe cases. Public health advocates and affected families frequently call for a review of the current policy, suggesting that the benefits of preventing severe disease outweigh the implementation costs, especially when considering the potential impact on student populations. The ongoing debate underscores the complex interplay between public health, resource management, and the desire to protect all vulnerable populations.
